Trailing-twelve-month (TTM) revenue is $112,000 with a year-over-year growth of (89.02%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $5,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q4 FY2025Period ended 2025-12-31 | $52,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-27 |
| Q1 FY2026Period ended 2026-03-31 | $22,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-14 |
| Q2 FY2026Period ended 2026-06-30 | $33,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $112,000 |
Current P/S: $17,234,340 market capitalization ÷ $112,000 TTM revenue = 153.88x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T17:05:23.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $33000.00.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:08:19.999Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2022-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD |
|---|---|---|
| Royalty | $100M | $100M |
$112,000
$112,000
(89.02%)
vs. $1.02M a year ago (TTM)
(48.07%)
3 Year compound annual growth rate
1 Year
(89.02%)
3 Year
(48.07%)
5 Year
N/A
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $71,000 | ($2.92M) | (97.63%) |
| 2024 | $3.00M | +$543,000 | +22.15% |
| 2023 | $2.45M | +$2.08M | +550.40% |
| 2022 | $377,000 | ($123,000) | (24.60%) |
TTM Growth
(89.02%)
3-Year CAGR
(48.07%)
5-Year CAGR
N/A
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 12 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T17:08:19.999Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
